S. Douc-Rasy

发表

A Ku80 fragment with dominant negative activity imparts a radiosensitive phenotype to CHO-K1 cells.

P. Jeggo, J. Bourhis, J. Bernier, 2000, Nucleic acids research.

Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts

J. Bourhis, J. Bernier, M. Barrois, 2000, Cancer Gene Therapy.

High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.

G. Riou, M. Barrois, J. Coll, 1996, Oncogene.

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma

B. Job, P. Dessen, C. Richon, 2011, British Journal of Cancer.

Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant

E. Ségal-Bendirdjian, S. Bombard, J. Hillion, 2012, Molecular Cancer Therapeutics.

CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells.

L. Meijer, J. Endicott, S. Baumli, 2010, Genes & cancer.

MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model.

J. Bénard, M. Barrois, S. Léonce, 2003, The American journal of pathology.

TP53 family members and human cancers

S. Douc-Rasy, S. Douc‐Rasy, J. Bénard, 2003, Human mutation.

p73α isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells

D. Cappellen, Matthieu Bauer, S. Douc-Rasy, 2008, Nucleic acids research.

DeltaN-p73alpha accumulates in human neuroblastic tumors.

M. Kaghad, D. Caput, U. Moll, 2002, The American journal of pathology.

A type I DNA topoisomerase from Trypanosoma cruzi.

G. Riou, M. Barrois, A. Kayser, 1983, European journal of biochemistry.

Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line

H. Haddada, M. Barrois, A. Legrand, 2004, Journal of Cell Science.

When p53 needs p73 to be functional - forced p73 expression induces nuclear accumulation of endogenous p53 protein.

H. Haddada, S. Douc-Rasy, G. Raguénez, 2003, Cancer letters.

ATP‐independent DNA topoisomerase II as potential drug target in trypanosomes

G. Riou, J. Riou, S. Douc-Rasy, 1988, Biology of the cell.

Netrin-1 acts as a survival factor for aggressive neuroblastoma

D. Cappellen, A. Nakagawara, A. Puisieux, 2009, The Journal of experimental medicine.

The neurogene BTG2TIS21/PC3 is transactivated by ΔNp73α via p53 specifically in neuroblastoma cells

E. May, A. Puisieux, H. Haddada, 2005, Journal of Cell Science.

Genomic and allelic expression status of the p73 gene in human neuroblastoma.

D. Caput, M. Barrois, A. Chompret, 2001, Medical and pediatric oncology.

Expression of C-terminal deleted p53 isoforms in neuroblastoma

E. May, G. Danglot, M. Guillaud-Bataille, 2006, Nucleic acids research.

Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients

G. Le Teuff, V. Combaret, P. Busson, 2014, Cancer medicine.

Inhibition of the reactions catalysed by a type I topoisomerase and catenating enzyme of Trypanosoma cruzi by DNA‐intercalating drugs. Preferential inhibition of the catenating reaction.

G. Riou, A. Kayser, S. Douc-Rasy, 1984, The EMBO journal.

Chromatin reconstitution on small DNA rings. IV. DNA supercoiling and nucleosome sequence preference.

S. Douc-Rasy, I. Duband-Goulet, A. Prunell, 1992, Journal of molecular biology.

Wnt-5a gene expression in malignant human neuroblasts.

S. Douc-Rasy, G. Raguénez, D. Goldschneider, 2005, Cancer letters.

(cid:1) N -p73 (cid:1) Accumulates in Human Neuroblastic Tumors

M. Kaghad, D. Caput, U. Moll, 2002 .

GALNT9 gene expression is a prognostic marker in neuroblastoma patients.

J. Bénard, E. Osinaga, D. Valteau‐Couanet, 2013, Clinical chemistry.

High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.

J. Armand, G. Riou, M. Barrois, 1995, Oncogene.

Association of c‐erbB2‐gene amplification with poor prognosis in non‐inflammatory breast carcinomas but not in carcinomas of the inflammatory type

J. Ahomadégbé, G. Riou, M. Spielmann, 1994, International journal of cancer.

c‐myc, p53 and bcl‐2, apoptosis‐related genes in infiltrating breast carcinomas: Evidence of a link between bcl‐2 protein over‐expression and a lower risk of metastasis and death in operable patients

M. Mathieu, G. Riou, M. Spielmann, 1999, International journal of cancer.

Differential regulation of p 73 variants in response to cisplatin treatment in SH-SY 5 Y neuroblastoma cells

F. Tournier, K. Million, S. Douc-Rasy, 2022 .

[High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium].

J. Armand, G. Riou, M. Barrois, 1996, Bulletin du cancer.